Samsung to launch AI health coach beta in US by end-2025
NEW YORK – Samsung Electronics Co. will roll out a beta version of AI-powered health coach within the Samsung Health application in the US by ...
Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma
BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...
South Korean eyewear poised to spark next global K-wave
As eyewear evolves into a key fashion statement, South Korea’s homegrown brands are setting their sights on the global stage with bold, unconv...
IFEZ to apply for designation of southern Ganghwa as free economic zone
The Incheon Free Economic Zone (IFEZ) Authority is set to submit its application by the end of June to designate the southern end of Ganghwa Island ...
Samsung Biologics to spin off biosimilar unit Samsung Bioepis
Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufac...
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Samsung seeks tech alliance with top US universities for robotics, AI, 6G
In an ambitious bid to shape the future of technology, Samsung Electronics Co. is launching a sweeping initiative to collaborate with elite North Am...
Celltrion expands footprint in Latin America with flagship oncology drugs
South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Samsung mobile chief fills leadership void in device division
Samsung Electronics Co. has appointed TM Roh, president and head of its mobile eXperience (MX) business, as the new chief of its device eXperience (...
Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...
SillaJen: First to use lab-grown human tissue to find best cancer drug dose
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...
S.Korean grocery delivery platform Oasis at forefront to acquire TMON
South Korea’s grocery delivery platform Oasis Corp., which has been looking to expand its e-commerce market at home and abroad, is seeking to ...
Chong Kun Dang to build new plant for foray into biologics market
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
HD Korea Shipbuilding premieres nuclear-powered ship design
HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE), the parent of the world’s largest shipbuilder HD Hyundai Heavy Industries Co.,...
Lotte Biologics eyes first ADC CDMO order in 2025
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut
SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...
SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US
South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
CLO Virtual Fashion raises $35 mn
South Korea's 3D digital fashion solution startup CLO Virtual Fashion said on Monday it raised 50 billion won ($35 million).Atinum Investment Co. an...
Boryung, Lotus Pharma signs CDMO deal on anticancer injection
South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...
SK Biopharm submits NDA of epilepsy drug to China
South Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...
Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug
Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...
Hanmi Pharma to move up launch of anti-obesity drug
South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
Samsung Heavy gets AIP for wing sails of LNGC
South Korea's Samsung Heavy Industries said on Wednesday that it received Approval in Principle (AIP) for a liquefied natural gas (LNG) carrier equi...
South Korea approves Korea Zinc’s precursor as national core technology
South Korea has designated Korea Zinc Inc.'s precursor manufacturing process as a national core technology and advanced industrial technology, effec...
Hyundai Motor unveils IONIQ 9 interior teaser
Hyundai Motor Co. unveiled a teaser image of the interior of its first large electric SUV, the IONIQ 9, on Wednesday.The IONIQ 9 is Hyundai’s ...
Hyundai Motor designs the future of mobility in Irvine studio
IRVINE, Calif. -- White sneakers, gray nail polish, pink goggles and orange remote controls are not something visitors expect to see in car design s...
